Objectives: We aimed to assess the effect of selective intracoronary hypothermia on outcomes in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).
Background: Intracoronary hypothermia, the feasibility and safety of which has been validated in humans, induced by selective trans-coronary infusion of saline at different temperatures can reduce infarct size (IS) prior to reperfusion in animal models of STEMI.
Methods: Sixty STEMI patients presenting with thrombolysis in myocardial infarction (TIMI) flow grade 0/1 were randomized after coronary artery angiography. Intracoronary hypothermia was induced by selective trans-coronary infusion of saline at 4°C to the endangered myocardium in the 30 patients. The primary endpoint, absolute IS expressed as IS/myocardium at risk (MaR), was assessed by cardiac magnetic resonance imaging at day 7 post-PPCI in 50 patients. Clinical follow-up was undertaken at day 30 after procedure.
Results: Intracoronary hypothermia was successfully performed in hypothermia group, without increase in arrhythmia or hemodynamic instability. The mean temperature reduction of 5.8 ± 1.1°C in distal coronary artery was achieved before reperfusion. Mean IS/MaR was predominantly reduced in the hypothermia group (44.85 ± 5.89% vs. 50.69 ± 10.75%, P = 0.022), especially in the anterior STEMI subgroup (46.12 ± 7.54% vs. 55.27 ± 11.175%, P = 0.023). The clinical events appeared no statistical difference between the two groups at the 30-day follow-up.
Conclusion: The statistical difference in IS/MaR by intracoronary hypothermia as adjunctive therapy to PPCI is an important observation and warrants a larger pivotal trial fully powered for efficacy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ccd.27864 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: design and rationale of the STEMI-Cool study.
Am Heart J
December 2024
Department of cardiology, Guy's and St Thomas' NHS Foundation Trust, Harefield Hospital, London, UK; King's College London, London, UK.
Background: ST-segment elevation myocardial infarction (STEMI) is treated with immediate primary percutaneous coronary intervention (pPCI) to restore coronary blood flow in the acutely ischaemic territory, but is associated with reperfusion injury limiting the benefit of the therapy. No treatment has proven effective in reducing reperfusion injury. Transcoronary hypothermia has been tested in clinical studies and is well tolerated, but is generally established after crossing the occlusion with a guidewire therefore after initial reperfusion, which might have contributed to the neutral outcomes.
View Article and Find Full Text PDFImpact of Mild Hypothermia As Adjunctive Therapy in Patients With ST-Elevation Myocardial Infarction: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.
Catheter Cardiovasc Interv
December 2024
Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
Background: The prevention of reperfusion injury remains an unmet need in ST-elevation myocardial infarction (STEMI) patients. Several randomized controlled trials (RCTs) evaluated mild hypothermia as adjunctive therapy during STEMI, with conflicting results.
Aims: To summarize the evidence about the efficacy and safety of mild hypothermia in patients with STEMI, as well as its conclusiveness through a trial sequential analysis (TSA).
Hypothermia for Cardioprotection in Acute Coronary Syndrome Patients: From Bench to Bedside.
J Clin Med
September 2024
First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokration General Hospital, 115 27 Athens, Greece.
Early revascularization for patients with acute myocardial infarction (AMI) is of outmost importance in limiting infarct size and associated complications, as well as for improving long-term survival and outcomes. However, reperfusion itself may further damage the myocardium and increase the infarct size, a condition commonly recognized as myocardial reperfusion injury. Several strategies have been developed for limiting the associated with reperfusion myocardial damage, including hypothermia.
View Article and Find Full Text PDFA randomised trial of selective intracoronary hypothermia during primary PCI.
EuroIntervention
June 2024
Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands.
Article Synopsis
- A study was done to see if cooling a part of the heart during a heart attack (called STEMI) would help reduce damage to it.
- 200 patients were divided into two groups: one group received cooling while the other did not.
- The results showed that the cooling didn’t make a significant difference in heart damage size compared to just the standard treatment.
A novel intracoronary hypothermia device reduces myocardial reperfusion injury in pigs.
Chin Med J (Engl)
October 2024
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Article Synopsis
- - The study investigated a new selective intracoronary hypothermia (SICH) device aimed at reducing heart damage caused by reperfusion injury after a myocardial infarction, demonstrating its feasibility, safety, and efficacy.
- - In a controlled experiment with pigs, the SICH method led to notable reductions in inflammatory markers and improved heart function, evidenced by smaller infarct sizes and better ejection fractions after the treatment compared to the control group.
- - Throughout the study, the SICH device was well-tolerated, showing no adverse effects on blood pressure or heart rate, and it effectively mitigated heart damage by addressing post-MI inflammatory responses and microvascular issues.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!